Literature DB >> 16019104

Changing pattern of hepatitis C virus spread in rural areas of Egypt.

Naglaa Arafa1, Mostafa El Hoseiny, Claire Rekacewicz, Iman Bakr, Sherif El-Kafrawy, Mai El Daly, Saeed Aoun, Diaa Marzouk, Mostafa K Mohamed, Arnaud Fontanet.   

Abstract

BACKGROUND/AIMS: To identify patterns of HCV spread in the Nile Delta of Egypt.
METHODS: Residents in a Nile Delta village were invited to participate in a cohort study of HCV infection. Risk factors for past or current infection were identified at cohort intake using generalized estimated equations models. Attributable fractions were calculated for all independent risk factors.
RESULTS: The prevalence of HCV antibodies increased from 2.7% in those <20 years of age to more than 40% in males aged 40-54 years. The peak in HCV prevalence in the 40-54 year age group corresponds to the aging of the cohort of children infected through schistosomiasis intravenous treatments in the 1960s-70s (accounting for 12.4% of all HCV infections observed today among adults). Following this initial founding event, the HCV epidemic has spread in the community through iatrogenic factors, and particularly injections (37.9% of the overall attributable fraction in adults). In children, however, no iatrogenic factors were associated with increased risk of infection, suggesting a change in the pattern of HCV spread.
CONCLUSIONS: While HCV infections in adults could be attributed to iatrogenic factors, and particularly injections, infections in children could not be explained by similar routes of transmission.

Entities:  

Mesh:

Year:  2005        PMID: 16019104     DOI: 10.1016/j.jhep.2005.03.021

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  30 in total

1.  Higher clearance of hepatitis C virus infection in females compared with males.

Authors:  I Bakr; C Rekacewicz; M El Hosseiny; S Ismail; M El Daly; S El-Kafrawy; G Esmat; M A Hamid; M K Mohamed; A Fontanet
Journal:  Gut       Date:  2006-01-24       Impact factor: 23.059

2.  Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection.

Authors:  Sayed F Abdelwahab; Zainab Zakaria; Maha Sobhy; Eman Rewisha; Mohamed A Mahmoud; Mahmoud A Amer; Mariarosaria Del Sorbo; Stefania Capone; Alfredo Nicosia; Antonella Folgori; Mohamed Hashem; Samer S El-Kamary
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

Review 3.  Guide for diagnosis and treatment of hepatocellular carcinoma.

Authors:  Magdy Hamed Attwa; Shahira Aly El-Etreby
Journal:  World J Hepatol       Date:  2015-06-28

Review 4.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

5.  Prospective study of prevalence and risk factors for hepatitis C in pregnant Egyptian women and its transmission to their infants.

Authors:  Khaled AbdulQawi; Ahmed Youssef; Mohamed A Metwally; Ibrahim Ragih; Mohamed AbdulHamid; AbdulAziz Shaheen
Journal:  Croat Med J       Date:  2010-06       Impact factor: 1.351

6.  Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt.

Authors:  D Marzouk; J Sass; I Bakr; M El Hosseiny; M Abdel-Hamid; C Rekacewicz; N Chaturvedi; M K Mohamed; A Fontanet
Journal:  Gut       Date:  2006-09-06       Impact factor: 23.059

7.  Evidence for a dominant major gene conferring predisposition to hepatitis C virus infection in endemic conditions.

Authors:  Cédric Laouénan; Sabine Plancoulaine; Mostafa Kamal Mohamed; Naglaa Arafa; Iman Bakr; Mohamed Abdel-Hamid; Claire Rekacewicz; Dorothée Obach; Arnaud Fontanet; Laurent Abel
Journal:  Hum Genet       Date:  2009-07-23       Impact factor: 4.132

8.  Patterns of hepatocellular carcinoma incidence in Egypt from a population-based cancer registry.

Authors:  Elizabeth M Lehman; Amr S Soliman; Kadry Ismail; Ahmed Hablas; Ibrahim A Seifeldin; Mohamed Ramadan; Hesham El-Hamzawy; Christiana S Shoushtari; Mark L Wilson
Journal:  Hepatol Res       Date:  2007-11-27       Impact factor: 4.288

9.  Injection drug use is a risk factor for HCV infection in urban Egypt.

Authors:  Adela Paez Jimenez; Mostafa K Mohamed; Noha Sharaf Eldin; Hasnaa Abou Seif; Said El Aidi; Yehia Sultan; Nasr Elsaid; Claire Rekacewicz; Mostafa El-Hoseiny; May El-Daly; Mohamed Abdel-Hamid; Arnaud Fontanet
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

10.  Symptomatic acute hepatitis C in Egypt: diagnosis, spontaneous viral clearance, and delayed treatment with 12 weeks of pegylated interferon alfa-2a.

Authors:  Noha Sharaf Eldin; Soheir Ismail; Hala Mansour; Claire Rekacewicz; Moustafa El-Houssinie; Sherif El-Kafrawy; Saeed El Aidi; Mohamed Abdel-Hamid; Gamal Esmat; Stanislas Pol; Arnaud Fontanet; Mostafa K Mohamed
Journal:  PLoS One       Date:  2008-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.